报道指华府再列中芯(00981.HK)等80间企业入商务部实体清单
《路透》引述消息人士指,华府将於当地时间周五(18日)将增加约80间企业列入美国商务部的实体清单,其中包括中芯(00981.HK),几乎所有遭列入企业皆为中国企业,相信相关企业与中国军方有关。被列入清单企业会有如华为,被限制接触美国技术。
报道指,目前该实体清单已包含超过275家中国公司和联属,包括华为、中兴(00763.HK)、海康威视(002415.SZ)等。
上月美国国防部已将中芯列入了所谓的中国军事公司的黑名单,有效禁止美国投资者从明年初开始购买其股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.